taVNS for Speech and Language Recovery in Aphasia

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
University of Florida
Study ID
NCT07563387
Status
Enrolling By Invitation

Conditions

  • Aphasia
  • Apraxia of Speech

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • taVNS — DEVICE
    active vagus nerve stimulation
  • sham taVNS — DEVICE
    sham vagus nerve stimulation

Study Details

The goal of this research study is to evaluate a novel approach to improving speech recovery in those with acquired apraxia of speech. We will enroll participants with apraxia of speech resulting from stroke or brain injury to complete several tasks and intervention. Testing will take place four times over the course of the study and intervention will take place 5 days a week for 16 weeks. Overall, you can expect to spend up to 17 weeks participating in this study.

Key Dates

Start date
Jan 1, 2026
Status verified
Jan 2026
Primary completion
Jan 1, 2027
Completion
Jan 1, 2028

Study Design

Enrollment
12 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment A
    non-invasive vagus nerve stimulation is administered alongside standard intervention
  • Placebo Comparator: Treatment B
    sham stimulation is administered alongside standard intervention

Primary Outcome Measure

Adverse events [ Time Frame: 6 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Brooks Rehabilitation Clinical Research CenterJacksonvilleFlorida32216-

Find similar trials in Jacksonville, FL

Related Studies